共 50 条
- [41] Discovery of Lanraplenib (GS-9876): A Once-Daily Spleen Tyrosine Kinase Inhibitor for Autoimmune DiseasesACS MEDICINAL CHEMISTRY LETTERS, 2020, 11 (04): : 506 - 513Blomgren, Peter论文数: 0 引用数: 0 h-index: 0机构: Gilead Sci, Seattle, WA 98102 USA Gilead Sci, Seattle, WA 98102 USAChandrasekhar, Jayaraman论文数: 0 引用数: 0 h-index: 0机构: Gilead Sci, Seattle, WA 98102 USA Gilead Sci, Seattle, WA 98102 USADi Paolo, Julie A.论文数: 0 引用数: 0 h-index: 0机构: Gilead Sci, Foster City, CA 94404 USA Gilead Sci, Seattle, WA 98102 USAFung, Wanchi论文数: 0 引用数: 0 h-index: 0机构: Gilead Sci, Foster City, CA 94404 USA Gilead Sci, Seattle, WA 98102 USAGeng, Guoju论文数: 0 引用数: 0 h-index: 0机构: Gilead Sci, Foster City, CA 94404 USA Gilead Sci, Seattle, WA 98102 USAIp, Carmen论文数: 0 引用数: 0 h-index: 0机构: Gilead Sci, Foster City, CA 94404 USA Gilead Sci, Seattle, WA 98102 USAJones, Randall论文数: 0 引用数: 0 h-index: 0机构: Gilead Sci, Seattle, WA 98102 USA Gilead Sci, Seattle, WA 98102 USAKropf, Jeffrey E.论文数: 0 引用数: 0 h-index: 0机构: Gilead Sci, Seattle, WA 98102 USA Gilead Sci, Seattle, WA 98102 USALansdon, Eric B.论文数: 0 引用数: 0 h-index: 0机构: Gilead Sci, Foster City, CA 94404 USA Gilead Sci, Seattle, WA 98102 USALee, Seung论文数: 0 引用数: 0 h-index: 0机构: Gilead Sci, Seattle, WA 98102 USA Gilead Sci, Seattle, WA 98102 USALo, Jennifer R.论文数: 0 引用数: 0 h-index: 0机构: Gilead Sci, Seattle, WA 98102 USA Gilead Sci, Seattle, WA 98102 USAMitchell, Scott A.论文数: 0 引用数: 0 h-index: 0机构: Gilead Sci, Seattle, WA 98102 USA Gilead Sci, Seattle, WA 98102 USAMurray, Bernard论文数: 0 引用数: 0 h-index: 0机构: Gilead Sci, Foster City, CA 94404 USA Gilead Sci, Seattle, WA 98102 USAPohlmeyer, Chris论文数: 0 引用数: 0 h-index: 0机构: Gilead Sci, Foster City, CA 94404 USA Gilead Sci, Seattle, WA 98102 USASchmitt, Aaron论文数: 0 引用数: 0 h-index: 0机构: Gilead Sci, Seattle, WA 98102 USA Gilead Sci, Seattle, WA 98102 USASuekawa-Pirrone, Kimberly论文数: 0 引用数: 0 h-index: 0机构: Gilead Sci, Foster City, CA 94404 USA Gilead Sci, Seattle, WA 98102 USAWise, Sarah论文数: 0 引用数: 0 h-index: 0机构: Gilead Sci, Foster City, CA 94404 USA Gilead Sci, Seattle, WA 98102 USAXiong, Jin-Ming论文数: 0 引用数: 0 h-index: 0机构: Gilead Sci, Seattle, WA 98102 USA Gilead Sci, Foster City, CA 94404 USA Gilead Sci, Seattle, WA 98102 USAXu, Jianjun论文数: 0 引用数: 0 h-index: 0机构: Gilead Sci, Seattle, WA 98102 USA Gilead Sci, Foster City, CA 94404 USA Gilead Sci, Seattle, WA 98102 USAYu, Helen论文数: 0 引用数: 0 h-index: 0机构: Gilead Sci, Foster City, CA 94404 USA Gilead Sci, Seattle, WA 98102 USAZhao, Zhongdong论文数: 0 引用数: 0 h-index: 0机构: Gilead Sci, Seattle, WA 98102 USA Gilead Sci, Foster City, CA 94404 USA Gilead Sci, Seattle, WA 98102 USACurrie, Kevin S.论文数: 0 引用数: 0 h-index: 0机构: Gilead Sci, Seattle, WA 98102 USA Gilead Sci, Seattle, WA 98102 USA
- [42] Discovery of the TYK2 selective inhibitor PF-6826647 for the treatment of Crohn's disease, and other autoimmune conditionsABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2018, 256Gerstenberger, Brian论文数: 0 引用数: 0 h-index: 0机构: Pfizer Inc, Med Design, Cambridge, MA USA Pfizer Inc, Inflammat & Immunol, Cambridge, MA USAArnold, Eric论文数: 0 引用数: 0 h-index: 0机构: Pfizer Inc, Med Design, Groton, CT 06340 USA Pfizer Inc, Inflammat & Immunol, Cambridge, MA USABanker, Mary Ellen论文数: 0 引用数: 0 h-index: 0机构: Pfizer Inc, Med Design, Groton, CT 06340 USA Pfizer Inc, Inflammat & Immunol, Cambridge, MA USABrown, Matthew论文数: 0 引用数: 0 h-index: 0机构: Pfizer Inc, Med Design, Groton, CT 06340 USA Pfizer Inc, Inflammat & Immunol, Cambridge, MA USAClark, James论文数: 0 引用数: 0 h-index: 0机构: Pfizer Inc, Inflammat & Immunol, Cambridge, MA USA Pfizer Inc, Inflammat & Immunol, Cambridge, MA USADermenci, Alpay论文数: 0 引用数: 0 h-index: 0机构: Pfizer Inc, Med Design, Groton, CT 06340 USA Pfizer Inc, Inflammat & Immunol, Cambridge, MA USADowty, Martin论文数: 0 引用数: 0 h-index: 0机构: Pfizer Inc, Med Design, Cambridge, MA USA Pfizer Inc, Inflammat & Immunol, Cambridge, MA USAFensome, Andrew论文数: 0 引用数: 0 h-index: 0机构: Pfizer Inc, Med Design, Cambridge, MA USA Pfizer Inc, Inflammat & Immunol, Cambridge, MA USAHayward, Matthew论文数: 0 引用数: 0 h-index: 0机构: Pfizer Inc, Med Design, Groton, CT 06340 USA Pfizer Inc, Inflammat & Immunol, Cambridge, MA USAHegen, Martin论文数: 0 引用数: 0 h-index: 0机构: Pfizer Inc, Inflammat & Immunol, Cambridge, MA USA Pfizer Inc, Inflammat & Immunol, Cambridge, MA USAHollingshead, Brett论文数: 0 引用数: 0 h-index: 0机构: Pfizer Inc, Drug Safety Res & Dev, Cambridge, MA USA Pfizer Inc, Inflammat & Immunol, Cambridge, MA USAKnafels, John论文数: 0 引用数: 0 h-index: 0机构: Pfizer Inc, Med Design, Groton, CT 06340 USA Pfizer Inc, Inflammat & Immunol, Cambridge, MA USALin, David论文数: 0 引用数: 0 h-index: 0机构: Pfizer Inc, Med Design, Groton, CT 06340 USA Pfizer Inc, Inflammat & Immunol, Cambridge, MA USALin, Tsung论文数: 0 引用数: 0 h-index: 0机构: Pfizer Inc, Inflammat & Immunol, Cambridge, MA USA Pfizer Inc, Inflammat & Immunol, Cambridge, MA USAOwen, Dafydd论文数: 0 引用数: 0 h-index: 0机构: Pfizer Inc, Med Design, Cambridge, MA USA Pfizer Inc, Inflammat & Immunol, Cambridge, MA USASaiah, Eddine论文数: 0 引用数: 0 h-index: 0机构: Pfizer Inc, Med Design, Cambridge, MA USA Pfizer Inc, Inflammat & Immunol, Cambridge, MA USASharma, Raman论文数: 0 引用数: 0 h-index: 0机构: Pfizer Inc, Med Design, Groton, CT 06340 USA Pfizer Inc, Inflammat & Immunol, Cambridge, MA USAVajdos, Felix论文数: 0 引用数: 0 h-index: 0机构: Pfizer Inc, Med Design, Groton, CT 06340 USA Pfizer Inc, Inflammat & Immunol, Cambridge, MA USAVincent, Fabien论文数: 0 引用数: 0 h-index: 0机构: Pfizer Inc, Med Design, Groton, CT 06340 USA Pfizer Inc, Inflammat & Immunol, Cambridge, MA USAWright, Stephen论文数: 0 引用数: 0 h-index: 0机构: Pfizer Inc, Med Design, Groton, CT 06340 USA Pfizer Inc, Inflammat & Immunol, Cambridge, MA USAXing, Li论文数: 0 引用数: 0 h-index: 0机构: Pfizer Inc, Med Design, Cambridge, MA USA Pfizer Inc, Inflammat & Immunol, Cambridge, MA USAYang, Xiaojing论文数: 0 引用数: 0 h-index: 0机构: Pfizer Inc, Med Design, Groton, CT 06340 USA Pfizer Inc, Inflammat & Immunol, Cambridge, MA USAYang, Xin论文数: 0 引用数: 0 h-index: 0机构: Pfizer Inc, Med Design, Groton, CT 06340 USA Pfizer Inc, Inflammat & Immunol, Cambridge, MA USAZhang, Liying论文数: 0 引用数: 0 h-index: 0机构: Pfizer Inc, Med Design, Cambridge, MA USA Pfizer Inc, Inflammat & Immunol, Cambridge, MA USA
- [43] Discovery of a Novel Inhaled PI3Kδ Inhibitor for the Treatment of Respiratory DiseasesJOURNAL OF MEDICINAL CHEMISTRY, 2018, 61 (21) : 9551 - 9567Erra, Montse论文数: 0 引用数: 0 h-index: 0机构: Almirall R&D, Med Chem & Screening, Barcelona 08980, Spain Almirall R&D, Med Chem & Screening, Barcelona 08980, SpainTaltavull, Joan论文数: 0 引用数: 0 h-index: 0机构: Almirall R&D, Med Chem & Screening, Barcelona 08980, Spain Almirall R&D, Med Chem & Screening, Barcelona 08980, SpainJavier Bernal, Francisco论文数: 0 引用数: 0 h-index: 0机构: Almirall R&D, Med Chem & Screening, Barcelona 08980, Spain Almirall R&D, Med Chem & Screening, Barcelona 08980, SpainFrancisco Caturla, Juan论文数: 0 引用数: 0 h-index: 0机构: Almirall R&D, Med Chem & Screening, Barcelona 08980, Spain Almirall R&D, Med Chem & Screening, Barcelona 08980, SpainCarrascal, Marta论文数: 0 引用数: 0 h-index: 0机构: Almirall R&D, Med Chem & Screening, Barcelona 08980, Spain Almirall R&D, Med Chem & Screening, Barcelona 08980, SpainPages, Lluis论文数: 0 引用数: 0 h-index: 0机构: Almirall R&D, Med Chem & Screening, Barcelona 08980, Spain Almirall R&D, Med Chem & Screening, Barcelona 08980, SpainMir, Marta论文数: 0 引用数: 0 h-index: 0机构: Almirall R&D, Med Chem & Screening, Barcelona 08980, Spain Almirall R&D, Med Chem & Screening, Barcelona 08980, SpainEspinosa, Sonia论文数: 0 引用数: 0 h-index: 0机构: Almirall R&D, Med Chem & Screening, Barcelona 08980, Spain Almirall R&D, Med Chem & Screening, Barcelona 08980, SpainGracia, Jordi论文数: 0 引用数: 0 h-index: 0机构: Almirall R&D, Med Chem & Screening, Barcelona 08980, Spain Almirall R&D, Med Chem & Screening, Barcelona 08980, SpainDominguez, Maria论文数: 0 引用数: 0 h-index: 0机构: Almirall R&D, Pharmacokinet & Metab, Barcelona 08980, Spain Almirall R&D, Med Chem & Screening, Barcelona 08980, SpainSabate, Mar论文数: 0 引用数: 0 h-index: 0机构: Almirall R&D, Pharmacokinet & Metab, Barcelona 08980, Spain Almirall R&D, Med Chem & Screening, Barcelona 08980, SpainParis, Stephane论文数: 0 引用数: 0 h-index: 0机构: Almirall R&D, Med Chem & Screening, Barcelona 08980, Spain Bionure Farma, Parc Cient Barcelona,Balidiri Reixac 4-8, Barcelona 08028, Spain Almirall R&D, Med Chem & Screening, Barcelona 08980, SpainMaldonado, Monica论文数: 0 引用数: 0 h-index: 0机构: Almirall R&D, Med Chem & Screening, Barcelona 08980, Spain Almirall R&D, Med Chem & Screening, Barcelona 08980, SpainHernandez, Begona论文数: 0 引用数: 0 h-index: 0机构: Almirall R&D, Med Chem & Screening, Barcelona 08980, Spain Palobiofarma SL, Plaza CEIN, Noain 31110, Spain Almirall R&D, Med Chem & Screening, Barcelona 08980, SpainBravo, Monica论文数: 0 引用数: 0 h-index: 0机构: Almirall R&D, Resp Therapeut Area, Barcelona 08980, Spain Almirall R&D, Med Chem & Screening, Barcelona 08980, SpainCalama, Elena论文数: 0 引用数: 0 h-index: 0机构: Almirall R&D, Resp Therapeut Area, Barcelona 08980, Spain Almirall R&D, Med Chem & Screening, Barcelona 08980, SpainMiralpeix, Montserrat论文数: 0 引用数: 0 h-index: 0机构: Almirall R&D, Resp Therapeut Area, Barcelona 08980, Spain Galapagos NV, Gen Wittelaan L11 A3, B-2800 Mechelen, Belgium Almirall R&D, Med Chem & Screening, Barcelona 08980, SpainLehner, Martin D.论文数: 0 引用数: 0 h-index: 0机构: Almirall R&D, Resp Therapeut Area, Barcelona 08980, Spain Bionorica SE, Kerschensteinerstr 11-15, D-92318 Neumarkt, Germany Almirall R&D, Med Chem & Screening, Barcelona 08980, SpainCalbet, Marta论文数: 0 引用数: 0 h-index: 0机构: Almirall R&D, Resp Therapeut Area, Barcelona 08980, Spain Almirall R&D, Med Chem & Screening, Barcelona 08980, Spain
- [44] Golimumab: A human anti-TNF-alpha monoclonal antibody for the treatment of autoimmune joint diseasesFORMULARY, 2009, 44 (09) : 264 - +Phung, Olivia J.论文数: 0 引用数: 0 h-index: 0机构: Univ Connecticut, Sch Pharm, Storrs, CT 06269 USAColeman, Craig I.论文数: 0 引用数: 0 h-index: 0机构: Univ Connecticut, Sch Pharm, Storrs, CT 06269 USA Univ Connecticut, Hartford Hosp, Evidence Based Practice Ctr, Storrs, CT 06269 USA Univ Connecticut, Sch Pharm, Storrs, CT 06269 USA
- [45] Characterization of a small molecule IRAK4 kinase inhibitor for the treatment of autoimmune and inflammatory diseasesJOURNAL OF IMMUNOLOGY, 2016, 196Lamagna, Chrystelle论文数: 0 引用数: 0 h-index: 0机构: Rigel Pharmaceut Inc, San Francisco, CA USA Rigel Pharmaceut Inc, San Francisco, CA USAChan, Meagan论文数: 0 引用数: 0 h-index: 0机构: Rigel Pharmaceut Inc, San Francisco, CA USA Rigel Pharmaceut Inc, San Francisco, CA USAYi, Sothy论文数: 0 引用数: 0 h-index: 0机构: Rigel Pharmaceut Inc, San Francisco, CA USA Rigel Pharmaceut Inc, San Francisco, CA USAYoung, Chi论文数: 0 引用数: 0 h-index: 0机构: Rigel Pharmaceut Inc, San Francisco, CA USA Rigel Pharmaceut Inc, San Francisco, CA USAFrances, Roy论文数: 0 引用数: 0 h-index: 0机构: Rigel Pharmaceut Inc, San Francisco, CA USA Rigel Pharmaceut Inc, San Francisco, CA USASiu, Stacey论文数: 0 引用数: 0 h-index: 0机构: Rigel Pharmaceut Inc, San Francisco, CA USA Rigel Pharmaceut Inc, San Francisco, CA USABraselmann, Sylvia论文数: 0 引用数: 0 h-index: 0机构: Rigel Pharmaceut Inc, San Francisco, CA USA Rigel Pharmaceut Inc, San Francisco, CA USAPayan, Donald G.论文数: 0 引用数: 0 h-index: 0机构: Rigel Pharmaceut Inc, San Francisco, CA USA Rigel Pharmaceut Inc, San Francisco, CA USAMcMurtrie, Darren论文数: 0 引用数: 0 h-index: 0机构: Rigel Pharmaceut Inc, San Francisco, CA USA Rigel Pharmaceut Inc, San Francisco, CA USAKelley, Ryan论文数: 0 引用数: 0 h-index: 0机构: Rigel Pharmaceut Inc, San Francisco, CA USA Rigel Pharmaceut Inc, San Francisco, CA USAHeckrodt, Thilo论文数: 0 引用数: 0 h-index: 0机构: Rigel Pharmaceut Inc, San Francisco, CA USA Rigel Pharmaceut Inc, San Francisco, CA USAYen, Rose论文数: 0 引用数: 0 h-index: 0机构: Rigel Pharmaceut Inc, San Francisco, CA USA Rigel Pharmaceut Inc, San Francisco, CA USAChen, Yan论文数: 0 引用数: 0 h-index: 0机构: Rigel Pharmaceut Inc, San Francisco, CA USA Rigel Pharmaceut Inc, San Francisco, CA USALi, Hui论文数: 0 引用数: 0 h-index: 0机构: Rigel Pharmaceut Inc, San Francisco, CA USA Rigel Pharmaceut Inc, San Francisco, CA USASingh, Rajinder论文数: 0 引用数: 0 h-index: 0机构: Rigel Pharmaceut Inc, San Francisco, CA USA Rigel Pharmaceut Inc, San Francisco, CA USAPark, Gary论文数: 0 引用数: 0 h-index: 0机构: Rigel Pharmaceut Inc, San Francisco, CA USA Rigel Pharmaceut Inc, San Francisco, CA USAMasuda, Esteban论文数: 0 引用数: 0 h-index: 0机构: Rigel Pharmaceut Inc, San Francisco, CA USA Rigel Pharmaceut Inc, San Francisco, CA USATaylor, Vanessa论文数: 0 引用数: 0 h-index: 0机构: Rigel Pharmaceut Inc, San Francisco, CA USA Rigel Pharmaceut Inc, San Francisco, CA USA
- [46] A novel specific inhibitor of PI3Kδ as a potential treatment for autoimmune blistering diseasesEXPERIMENTAL DERMATOLOGY, 2015, 24 (12) : 984 - 984Balague, C.论文数: 0 引用数: 0 h-index: 0机构: Almirall R&D, Sant Feliu de Llobregat, Spain Almirall R&D, Sant Feliu de Llobregat, SpainKoga, H.论文数: 0 引用数: 0 h-index: 0机构: Lubeck Inst Expt Dermatol, Lubeck, Germany Almirall R&D, Sant Feliu de Llobregat, SpainKasprick, A.论文数: 0 引用数: 0 h-index: 0机构: Lubeck Inst Expt Dermatol, Lubeck, Germany Almirall R&D, Sant Feliu de Llobregat, SpainLudwig, R.论文数: 0 引用数: 0 h-index: 0机构: Lubeck Inst Expt Dermatol, Lubeck, Germany Almirall R&D, Sant Feliu de Llobregat, SpainPont, M.论文数: 0 引用数: 0 h-index: 0机构: Almirall R&D, Sant Feliu de Llobregat, Spain Almirall R&D, Sant Feliu de Llobregat, SpainLopez, R.论文数: 0 引用数: 0 h-index: 0机构: Almirall R&D, Sant Feliu de Llobregat, Spain Almirall R&D, Sant Feliu de Llobregat, SpainAuli, M.论文数: 0 引用数: 0 h-index: 0机构: Almirall R&D, Sant Feliu de Llobregat, Spain Almirall R&D, Sant Feliu de Llobregat, SpainGodessart, N.论文数: 0 引用数: 0 h-index: 0机构: Almirall R&D, Sant Feliu de Llobregat, Spain Almirall R&D, Sant Feliu de Llobregat, Spain
- [47] Discovery and Characterization of a Selective, Orally Bioavailable PAD4 Inhibitor to Target NETs Driven Autoimmune and Inflammatory DiseasesARTHRITIS & RHEUMATOLOGY, 2023, 75 : 81 - 82Yang, Min论文数: 0 引用数: 0 h-index: 0机构: Regor Therapeut, Shanghai, Peoples R China Regor Therapeut, Shanghai, Peoples R ChinaFeng, song论文数: 0 引用数: 0 h-index: 0机构: Regor Therapeut, Shanghai, Peoples R China Regor Therapeut, Shanghai, Peoples R ChinaWen, Yuling论文数: 0 引用数: 0 h-index: 0机构: Regor Therapeut, Shanghai, Peoples R China Regor Therapeut, Shanghai, Peoples R ChinaRen, Xiaoming论文数: 0 引用数: 0 h-index: 0机构: Regor Therapeut, Shanghai, Peoples R China Regor Therapeut, Shanghai, Peoples R ChinaLi, Huijuan论文数: 0 引用数: 0 h-index: 0机构: Regor Therapeut, Shanghai, Peoples R China Regor Therapeut, Shanghai, Peoples R ChinaYao, lili论文数: 0 引用数: 0 h-index: 0机构: Regor Therapeut, Shanghai, Peoples R China Regor Therapeut, Shanghai, Peoples R Chinaxie, Zhi论文数: 0 引用数: 0 h-index: 0机构: Regor Pharmaceut Inc, San Francisco, CA USA Regor Therapeut, Shanghai, Peoples R Chinazhong, Wenge论文数: 0 引用数: 0 h-index: 0机构: Regor Therapeut, Shanghai, Peoples R China Regor Therapeut, Shanghai, Peoples R China
- [48] ShK-186 from Discovery to Clinical Development for the Treatment of Multiple Sclerosis and Other Autoimmune DiseasesBIOPOLYMERS, 2013, 100 (03) : 237 - 237Pennington, M. W.论文数: 0 引用数: 0 h-index: 0机构: Peptides Int Inc, Louisville, KY 40299 USA Peptides Int Inc, Louisville, KY 40299 USAChandy, K. G.论文数: 0 引用数: 0 h-index: 0机构: Univ CA, Dept Biophys & Physiol, Irvine, CA 92697 USA Peptides Int Inc, Louisville, KY 40299 USABeeton, C.论文数: 0 引用数: 0 h-index: 0机构: Baylor Coll Med, Houston, TX 77030 USA Peptides Int Inc, Louisville, KY 40299 USAIodonato, S.论文数: 0 引用数: 0 h-index: 0机构: Baylor Coll Med, Houston, TX 77030 USA Kineta Inc, Seattle, WA 98109 USA Peptides Int Inc, Louisville, KY 40299 USATarcha, E.论文数: 0 引用数: 0 h-index: 0机构: Kineta Inc, Seattle, WA 98109 USA Peptides Int Inc, Louisville, KY 40299 USANorton, R. S.论文数: 0 引用数: 0 h-index: 0机构: Monash Inst Pharmaceut Sci, Parkville, Vic 3052, Australia Peptides Int Inc, Louisville, KY 40299 USA
- [49] Discovery of the TLR7/8 Antagonist MHV370 for Treatment of Systemic Autoimmune DiseasesACS MEDICINAL CHEMISTRY LETTERS, 2023, 14 (08): : 1054 - 1062Alper, Phil论文数: 0 引用数: 0 h-index: 0机构: Novartis Inst Biomed Res, San Diego, CA 92121 USA Novartis Inst Biomed Res, CH-4056 Basel, SwitzerlandBetschart, Claudia论文数: 0 引用数: 0 h-index: 0机构: Novartis Inst Biomed Res, CH-4056 Basel, Switzerland Novartis Inst Biomed Res, CH-4056 Basel, SwitzerlandAndre, Ceïdric论文数: 0 引用数: 0 h-index: 0机构: Novartis Inst Biomed Res, CH-4056 Basel, Switzerland Novartis Inst Biomed Res, CH-4056 Basel, SwitzerlandBoulay, Thomas论文数: 0 引用数: 0 h-index: 0机构: Novartis Inst Biomed Res, CH-4056 Basel, Switzerland Novartis Inst Biomed Res, CH-4056 Basel, SwitzerlandCheng, Dai论文数: 0 引用数: 0 h-index: 0机构: Novartis Inst Biomed Res, San Diego, CA 92121 USA Novartis Inst Biomed Res, CH-4056 Basel, SwitzerlandDeane, Jonathan论文数: 0 引用数: 0 h-index: 0机构: Novartis Inst Biomed Res, San Diego, CA 92121 USA Novartis Inst Biomed Res, CH-4056 Basel, SwitzerlandFaller, Michael论文数: 0 引用数: 0 h-index: 0机构: Novartis Inst Biomed Res, CH-4056 Basel, Switzerland Novartis Inst Biomed Res, CH-4056 Basel, SwitzerlandFeifel, Roland论文数: 0 引用数: 0 h-index: 0机构: Novartis Inst Biomed Res, CH-4056 Basel, Switzerland Novartis Inst Biomed Res, CH-4056 Basel, SwitzerlandGlatthar, Ralf论文数: 0 引用数: 0 h-index: 0机构: Novartis Inst Biomed Res, CH-4056 Basel, Switzerland Novartis Inst Biomed Res, CH-4056 Basel, SwitzerlandHan, Dong论文数: 0 引用数: 0 h-index: 0机构: Novartis Inst Biomed Res, San Diego, CA 92121 USA Novartis Inst Biomed Res, CH-4056 Basel, SwitzerlandHemmig, Rene论文数: 0 引用数: 0 h-index: 0机构: Novartis Inst Biomed Res, CH-4056 Basel, Switzerland Novartis Inst Biomed Res, CH-4056 Basel, SwitzerlandJiang, Tao论文数: 0 引用数: 0 h-index: 0机构: Novartis Inst Biomed Res, San Diego, CA 92121 USA Novartis Inst Biomed Res, CH-4056 Basel, SwitzerlandKnoepfel, Thomas论文数: 0 引用数: 0 h-index: 0机构: Novartis Inst Biomed Res, CH-4056 Basel, Switzerland Novartis Inst Biomed Res, CH-4056 Basel, SwitzerlandMaginnis, Jillian论文数: 0 引用数: 0 h-index: 0机构: Novartis Inst Biomed Res, San Diego, CA 92121 USA Novartis Inst Biomed Res, CH-4056 Basel, SwitzerlandMutnick, Daniel论文数: 0 引用数: 0 h-index: 0机构: Novartis Inst Biomed Res, San Diego, CA 92121 USA Novartis Inst Biomed Res, CH-4056 Basel, SwitzerlandPei, Wei论文数: 0 引用数: 0 h-index: 0机构: Novartis Inst Biomed Res, San Diego, CA 92121 USA Novartis Inst Biomed Res, CH-4056 Basel, SwitzerlandRuzzante, Giulia论文数: 0 引用数: 0 h-index: 0机构: Novartis Inst Biomed Res, CH-4056 Basel, Switzerland Novartis Inst Biomed Res, CH-4056 Basel, SwitzerlandSyka, Peter论文数: 0 引用数: 0 h-index: 0机构: Novartis Inst Biomed Res, San Diego, CA 92121 USA Novartis Inst Biomed Res, CH-4056 Basel, SwitzerlandZhang, Guobao论文数: 0 引用数: 0 h-index: 0机构: Novartis Inst Biomed Res, San Diego, CA 92121 USA Novartis Inst Biomed Res, CH-4056 Basel, SwitzerlandZhang, Yi论文数: 0 引用数: 0 h-index: 0机构: Novartis Inst Biomed Res, San Diego, CA 92121 USA Novartis Inst Biomed Res, CH-4056 Basel, SwitzerlandZink, Florence论文数: 0 引用数: 0 h-index: 0机构: Novartis Inst Biomed Res, CH-4056 Basel, Switzerland Novartis Inst Biomed Res, CH-4056 Basel, SwitzerlandZipfel, Geraldine论文数: 0 引用数: 0 h-index: 0机构: Novartis Inst Biomed Res, CH-4056 Basel, Switzerland Novartis Inst Biomed Res, CH-4056 Basel, SwitzerlandHawtin, Stuart论文数: 0 引用数: 0 h-index: 0机构: Novartis Inst Biomed Res, CH-4056 Basel, Switzerland Novartis Inst Biomed Res, CH-4056 Basel, SwitzerlandJunt, Tobias论文数: 0 引用数: 0 h-index: 0机构: Novartis Inst Biomed Res, CH-4056 Basel, Switzerland Novartis Inst Biomed Res, CH-4056 Basel, SwitzerlandMichellys, Pierre-Yves论文数: 0 引用数: 0 h-index: 0机构: Novartis Inst Biomed Res, San Diego, CA 92121 USA Novartis Inst Biomed Res, CH-4056 Basel, Switzerland
- [50] Structures of EBI2 shed light on the treatment of autoimmune diseasesSTRUCTURE, 2022, 30 (07) : 922 - 924Shen, Jinkang论文数: 0 引用数: 0 h-index: 0机构: Zhejiang Univ, Coll Pharmaceut Sci, Hangzhou Inst Innovat Med, Inst Pharmacol & Toxicol,Zhejiang Prov Key Lab An, Hangzhou 310058, Zhejiang, Peoples R China Zhejiang Univ, Coll Pharmaceut Sci, Hangzhou Inst Innovat Med, Inst Pharmacol & Toxicol,Zhejiang Prov Key Lab An, Hangzhou 310058, Zhejiang, Peoples R ChinaZhang, Haitao论文数: 0 引用数: 0 h-index: 0机构: Zhejiang Univ, Coll Pharmaceut Sci, Hangzhou Inst Innovat Med, Inst Pharmacol & Toxicol,Zhejiang Prov Key Lab An, Hangzhou 310058, Zhejiang, Peoples R China Zhejiang Univ, Affiliated Hosp 2, Sch Med, Hangzhou 310009, Zhejiang, Peoples R China Zhejiang Univ, Coll Pharmaceut Sci, Hangzhou Inst Innovat Med, Inst Pharmacol & Toxicol,Zhejiang Prov Key Lab An, Hangzhou 310058, Zhejiang, Peoples R China